These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36012707)

  • 1. Serotonin 5-HT
    Więckowski K; Szałaj N; Gryzło B; Wichur T; Góral I; Sługocka E; Sniecikowska J; Latacz G; Siwek A; Godyń J; Bucki A; Kołaczkowski M; Więckowska A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer's disease.
    Wichur T; Więckowska A; Więckowski K; Godyń J; Jończyk J; Valdivieso ÁDR; Panek D; Pasieka A; Sabaté R; Knez D; Gobec S; Malawska B
    Eur J Med Chem; 2020 Feb; 187():111916. PubMed ID: 31812794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 1-(phenylsulfonyl)-1H-indole-based multifunctional ligands targeting cholinesterases and 5-HT
    Wichur T; Pasieka A; Godyń J; Panek D; Góral I; Latacz G; Honkisz-Orzechowska E; Bucki A; Siwek A; Głuch-Lutwin M; Knez D; Brazzolotto X; Gobec S; Kołaczkowski M; Sabate R; Malawska B; Więckowska A
    Eur J Med Chem; 2021 Dec; 225():113783. PubMed ID: 34461507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-Alzheimer's multitarget-directed ligands with serotonin 5-HT
    Marcinkowska M; Bucki A; Panek D; Siwek A; Fajkis N; Bednarski M; Zygmunt M; Godyń J; Del Rio Valdivieso A; Kotańska M; Kołaczkowski M; Więckowska A
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900041. PubMed ID: 31162703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease.
    Lan JS; Xie SS; Li SY; Pan LF; Wang XB; Kong LY
    Bioorg Med Chem; 2014 Nov; 22(21):6089-104. PubMed ID: 25282654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifunctional novel Diallyl disulfide (DADS) derivatives with β-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer's disease.
    Manral A; Saini V; Meena P; Tiwari M
    Bioorg Med Chem; 2015 Oct; 23(19):6389-403. PubMed ID: 26337018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT
    Więckowska A; Kołaczkowski M; Bucki A; Godyń J; Marcinkowska M; Więckowski K; Zaręba P; Siwek A; Kazek G; Głuch-Lutwin M; Mierzejewski P; Bienkowski P; Sienkiewicz-Jarosz H; Knez D; Wichur T; Gobec S; Malawska B
    Eur J Med Chem; 2016 Nov; 124():63-81. PubMed ID: 27560283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of oxidative stress and other pathologies in Alzheimer's disease.
    Simunkova M; Alwasel SH; Alhazza IM; Jomova K; Kollar V; Rusko M; Valko M
    Arch Toxicol; 2019 Sep; 93(9):2491-2513. PubMed ID: 31440798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and crystallography-aided SAR studies of multifunctional BuChE inhibitors and 5-HT
    Wichur T; Godyń J; Góral I; Latacz G; Bucki A; Siwek A; Głuch-Lutwin M; Mordyl B; Śniecikowska J; Walczak M; Knez D; Jukič M; Sałat K; Gobec S; Kołaczkowski M; Malawska B; Brazzolotto X; Więckowska A
    Eur J Med Chem; 2021 Dec; 225():113792. PubMed ID: 34530376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of chalcone-O-alkylamine derivatives as multifunctional agents against Alzheimer's disease.
    Bai P; Wang K; Zhang P; Shi J; Cheng X; Zhang Q; Zheng C; Cheng Y; Yang J; Lu X; Sang Z
    Eur J Med Chem; 2019 Dec; 183():111737. PubMed ID: 31581002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multi-target-directed ligands for treating Alzheimer's disease: Butyrylcholinesterase inhibitors displaying antioxidant and neuroprotective activities.
    Knez D; Coquelle N; Pišlar A; Žakelj S; Jukič M; Sova M; Mravljak J; Nachon F; Brazzolotto X; Kos J; Colletier JP; Gobec S
    Eur J Med Chem; 2018 Aug; 156():598-617. PubMed ID: 30031971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromone-lipoic acid conjugate: Neuroprotective agent having acceptable butyrylcholinesterase inhibition, antioxidant and copper-chelation activities.
    Jalili-Baleh L; Nadri H; Forootanfar H; Küçükkılınç TT; Ayazgök B; Sharifzadeh M; Rahimifard M; Baeeri M; Abdollahi M; Foroumadi A; Khoobi M
    Daru; 2021 Jun; 29(1):23-38. PubMed ID: 33420969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological evaluation of 2-arylethenylquinoline derivatives as multifunctional agents for the treatment of Alzheimer's disease.
    Wang XQ; Xia CL; Chen SB; Tan JH; Ou TM; Huang SL; Li D; Gu LQ; Huang ZS
    Eur J Med Chem; 2015 Jan; 89():349-61. PubMed ID: 25462251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease.
    Zaręba P; Łątka K; Mazur G; Gryzło B; Pasieka A; Godyń J; Panek D; Skrzypczak-Wiercioch A; Höfner GC; Latacz G; Maj M; Espargaró A; Sabaté R; Jóźwiak K; Wanner KT; Sałat K; Malawska B; Kulig K; Bajda M
    Eur J Med Chem; 2023 Dec; 261():115832. PubMed ID: 37837674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tacrine-based Multifunctional Agents in Alzheimer's Disease: An Old Story in Continuous Development§.
    Milelli A; De Simone A; Ticchi N; Chen HH; Betari N; Andrisano V; Tumiatti V
    Curr Med Chem; 2017; 24(32):3522-3546. PubMed ID: 28294041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease.
    Więckowska A; Wichur T; Godyń J; Bucki A; Marcinkowska M; Siwek A; Więckowski K; Zaręba P; Knez D; Głuch-Lutwin M; Kazek G; Latacz G; Mika K; Kołaczkowski M; Korabecny J; Soukup O; Benkova M; Kieć-Kononowicz K; Gobec S; Malawska B
    ACS Chem Neurosci; 2018 May; 9(5):1195-1214. PubMed ID: 29384656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrine-hydroxamate derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease: Design, synthesis, and biological evaluation.
    Xu A; He F; Zhang X; Li X; Ran Y; Wei C; James Chou C; Zhang R; Wu J
    Bioorg Chem; 2020 May; 98():103721. PubMed ID: 32193030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Wu J; Kou X; Ju H; Zhang H; Yang A; Shen R
    Bioorg Med Chem Lett; 2021 Oct; 49():128316. PubMed ID: 34391893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis and Evaluation of Novel Tacrine-Ferulic Acid Hybrids as Multifunctional Drug Candidates against Alzheimer's Disease.
    Fu Y; Mu Y; Lei H; Wang P; Li X; Leng Q; Han L; Qu X; Wang Z; Huang X
    Molecules; 2016 Oct; 21(10):. PubMed ID: 27727187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design Synthesis and
    Remya RS; Ramalakshmi N; Nalini CN; Niraimathi V; Amuthalakshmi S
    Curr Comput Aided Drug Des; 2022; 18(4):271-292. PubMed ID: 35927818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.